Effects of dithiothreitol on the amyloid fibrillogenesis of hen egg-white lysozyme

Ahmad F, Taneja S, Yadav S, Haque SE (1994) A new method for testing the functional dependence of unfolding free-energy changes on denaturant concentration. J Biochem 115:322–327

Aso Y, Shiraki K, Takagi M (2007) Systematic analysis of aggregates from 38 kinds of non disease-related proteins: identifying the intrinsic propensity of polypeptides to form amyloid fibrils. Biosci Biotechnol Biochem 71:1313–1321

Bennett MC (2005) The role of alpha-synuclein in neurodegenerative diseases. Pharmacol Ther 105:311–331

Betz SF (1993) Disulfide bonds and the stability of globular-proteins. Protein Sci 2:1551–1558

Bliznyukov OP, Kozmin LD, Vysotskaya LL, Golenkov AK, Tishchenko VM, Samoylovich MP, Klimovich VB (2005) Human immunoglobulin light chains lambda form amyloid fibrils and granular aggregates in solution. Biochemistry-Moscow 70:458–466

Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, Fraser PE, Hawkins PN, Dobson CM, Radford SE, Blake CCF, Pepys MB (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385:787–793

Bulaj G (2005) Formation of disulfide bonds in proteins and peptides. Biotechnol Adv 23:87–92

Chen S, Berthelier V, Hamilton JB, O’Nuallai B, Wetzel R (2002) Amyloid-like features of polyglutamine aggregates and their assembly kinetics. Biochemistry 41:7391–7399

Chiti F, Dobson CM (2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75:333–366

Chiti F, Dobson CM (2009) Amyloid formation by globular proteins under native conditions. Nat Chem Biol 5:15–22

Clarke J, Fersht AR (1993) Engineered disulfide bonds as probes of the folding pathway of barnase—increasing the stability of proteins against the rate of denaturation. Biochemistry 32:4322–4329

Creighton TE (1984) Disulfide bond formation in proteins. Methods Enzymol 107:305–329

Dabora JM, Sanyal G, Middaugh CR (1991) Effect of polyanions on the refolding of human acidic fibroblast growth factor. J Biol Chem 266:23637–23640

Das AK, Drew MG, Haldar D, Banerjee A (2005) The role of the disulfide bond in amyloid-like fibrillogenesis in a model peptide system. Org Biomol Chem 3:3502–3507

De Bernardez Clark E (2001) Protein refolding for industrial processes. Curr Opin Biotechnol 12:202–207

De Bernardez Clark E, Hevehan D, Szela S, Maachupalli-Reddy J (1998) Oxidative renaturation of hen egg-white lysozyme. Folding vs aggregation. Biotechnol Progress 14:47–54

De Bernardez Clark E, Schwarz E, Rudolph R (1999) Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol 309:217–236

Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15:3–16

El-Agnaf OM, Sheridan JM, Sidera C, Siligardi G, Hussain R, Haris PI, Austen BM (2001) Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia. Biochemistry 40:3449–3457

Estrada LD, Soto C (2007) Disrupting beta-amyloid aggregation for Alzheimer disease treatment. Curr Top Med Chem 7:115–126

Fandrich M, Forge V, Buder K, Kittler M, Dobson CM, Diekmann S (2003) Myoglobin forms amyloid fibrils by association of unfolded polypeptide segments. Proc Natl Acad Sci USA 100:15463–15468

Ferrao-Gonzales AD, Souto SO, Silva JL, Foguel D (2000) The preaggregated state of an amyloidogenic protein: hydrostatic pressure converts native transthyretin into the amyloidogenic state. Proc Natl Acad Sci U S A 97:6445–6450

Frare E, de Laureto PP, Zurdo J, Dobson CM, Fontana A (2004) A highly amyloidogenic region of hen lysozyme. J Mol Biol 340:1153–1165

Gazova Z, Bellova A, Daxnerova Z, Imrich J, Kristian P, Tomascikova J, Bagelova J, Fedunova D, Antalik M (2008) Acridine derivatives inhibit lysozyme aggregation. Eur Biophys J 37:1261–1270

Goedert M, Spillantini MG (2006) A century of Alzheimer’s disease. Science 314:777–781

Greene RF, Pace CN (1974) Urea and guanidine-hydrochloride denaturation of ribonuclease, lysozyme, alpha-chymotrypsin, and beta-lactoglobulin. J Biol Chem 249:5388–5393

Hong D-P, Ahmad A, Fink AL (2006) Fibrillation of human insulin A and B chains. Biochemistry 45:9342–9353

Kallberg Y, Gustafsson M, Persson B, Thyberg J, Johansson J (2001) Prediction of amyloid fibril-forming proteins. J Biol Chem 276:12945–12950

Kells DIC, O’Neil JDJ, Hofmann T (1984) A method for eliminating Rayleigh scattering from fluorescence spectra. Anal Biochem 139:316–318

Khurana R, Ionescu-Zanetti C, Pope M, Li J, Nielson L, Ramírez-Alvarado M, Regan L, Fink AL, Carter SA (2003) A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys J 85:1135–1144

Krebs MR, Wilkins DK, Chung EW, Pitkeathly MC, Chamberlain AK, Zurdo J, Robinson CV, Dobson CM (2000) Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the beta-domain. J Mol Biol 300:541–549

Kumar S, Ravi VK, Swaminathan R (2008) How do surfactants and DTT affect the size, dynamics, activity and growth of soluble lysozyme aggregates? Biochem J 415:275–288

Lai Z, Colon W, Kelly JW (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry 35:6470–6482

Lansbury PT Jr (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc Natl Acad Sci U S A 96:3342–3344

Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121–1159

LeVine H 3rd (1993) Thioflavine T interaction with synthetic Alzheimer’s disease beta- amyloid peptides: detection of amyloid aggregation in solution. Protein Sci 2:404–410

Liu CP, Li ZY, Huang GC, Perrett S, Zhou JM (2005) Two distinct intermediates of trigger factor are populated during guanidine denaturation. Biochimie 87:1023–1031

Mishra R, Sorgjerd K, Nystrom S, Nordigarden A, Yu YC, Hammarstrom P (2007) Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion. J Mol Biol 366:1029–1044

Morozova-Roche L, Malisauskas M (2007) A false paradise—mixed blessings in the protein universe: the amyloid as a new challenge in drug development. Curr Med Chem 14:1221–1230

Munishkina LA, Cooper EM, Uversky VN, Fink AL (2004) The effect of macromolecular crowding on protein aggregation and amyloid fibril formation. J Mol Recognit 17:456–464

Nakatani H, Maki K, Saeki K, Aizawa T, Demura M, Kawano K, Tomoda S, Kuwajima K (2007) Equilibrium and kinetics of the folding and unfolding of canine milk lysozyme. Biochemistry 46:5238–5251

Ohhashi Y, Hagihara Y, Kozhukh G, Hoshino M, Hasegawa K, Yamaguchi I, Naiki H, Goto Y (2002) The intrachain disulfide bond of beta(2)-microglobulin is not essential for the immunoglobulin fold at neutral pH, but is essential for amyloid fibril formation at acidic pH. J Biochem 131:45–52

Ohnishi S, Takano K (2004) Amyloid fibrils from the viewpoint of protein folding. Cell Mol Life Sci 61:511–524

Oobatake M, Takahashi S, Ooi T (1979) Conformational stability of ribonuclease-T1. 2. Salt-induced renaturation. J Biochem 86:65–70

Paik SR, Lee D, Cho H-J, Lee E-N, Chang C-S (2003) Oxidized glutathione stimulated the amyloid formation of [alpha]-synuclein. FEBS Lett 537:63–67

Pedersen JS, Christensen G, Otzen DE (2004) Modulation of S6 fibrillation by unfolding rates and gatekeeper residues. J Mol Biol 341:575–588

Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ et al (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 362:553–557

Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67:27–37

Powers ET, Powers DL (2008) Mechanisms of protein fibril formation: Nucleated polymerization with competing off-pathway aggregation. Biophys J 94:379–391

Privalov PL (1996) Intermediate states in protein folding. J Mol Biol 258:707–725

Rodionova NA, Semisotnov GV, Kutyshenko VP, Uverskii VN, Bolotina IA (1989) Staged equilibrium of carbonic anhydrase unfolding in strong denaturants. Mol Biol (Mosk) 23:683–692

Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10(Suppl):S10–S17

Sasahara K, Demura M, Nitta K (2002) Equilibrium and kinetic folding of hen egg-white lysozyme under acidic conditions. Proteins-Struc Funct Genet 49:472–482

Semisotnov GV, Rodionova NA, Razgulyaev OI, Uversky VN, Gripas AF, Gilmanshin RI (1991) Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe. Biopolymers 31:119–128

Serpell LC, Sunde M, Benson MD, Tennent GA, Pepys MB, Fraser PE (2000) The protofilament substructure of amyloid fibrils. J Mol Biol 300:1033–1039

Shimizu S, Shimizu K (1999) Alcohol denaturation: thermodynamic theory of peptide unit solvation. J Am Chem Soc 121:2387–2394

Shtilerman MD, Ding TT, Lansbury PT Jr (2002) Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson’s disease? Biochemistry 41:3855–3860

Singh SM, Panda AK (2005) Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng 99:303–310

Sirangelo I, Bismuto E, Tavassi S, Irace G (1998) Apomyoglobin folding intermediates characterized by the hydrophobic fluorescent probe 8-anilino-1-naphthalene sulfonate. Biochim Biophys Acta 1385:69–77

Smoot AL, Panda M, Brazil BT, Buckle AM, Fersht AR, Horowitz PM (2001) The binding of bis-ANS to the isolated GroEL apical domain fragment induces the formation of a folding intermediate with increased hydrophobic surface not observed in tetradecameric GroEL. Biochemistry 40:4484–4492

Srisailam S, Kumar TKS, Srimathi T, Yu C (2002) Influence of backbone conformation on protein aggregation. J Am Chem Soc 124:1884–1888

Srisailam S, Kumar TKS, Rajalingam D, Kathir KM, Sheu H-S, Jan F-J, Chao P-C, Yu C (2003) Amyloid-like Fibril formation in an all β-barrel protein. J Biol Chem 278:17701–17709

Taylor JP, Hardy J, Fischbeck KH (2002) Toxic proteins in neurodegenerative disease. Science 296:1991–1995

Thakur AK, Rao CM (2008) UV-light exposed prion protein fails to form amyloid fibrils. PLoS ONE 3:e2688

Thorn DC, Ecroyd H, Sunde M, Poon S, Carver JA (2008) Amyloid fibril formation by bovine milk alpha s2-casein occurs under physiological conditions yet is prevented by its natural counterpart, alpha s1-casein. Biochemistry 47:3926–3936

Uversky VN, Fink AL (2004) Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim Biophys Acta 1698:131–153

Vaney MC, Maignan S, Ries-Kautt M, Ducriux A (1996) High-resolution structure (1.33 A) of a HEW lysozyme tetragonal crystal grown in the APCF apparatus. Data and structural comparison with a crystal grown under microgravity from SpaceHab-01 mission. Acta Crystallogr D Biol Crystallogr 52:505–517

Vetri V, Canale C, Relini A, Librizzi F, Militello V, Gliozzi A, Leone M (2007) Amyloid fibrils formation and amorphous aggregation in concanavalin A. Biophys Chem 125:184–190

Wang W (2005) Protein aggregation and its inhibition in biopharmaceutics. Int J Pharm 289:1–30

Wang SSS, Good TA (2005) An overview of Alzheimer’s disease. J Chin Inst Chem Eng 36:533–559

Wang SSS, Chou SW, Liu KN, Wu CH (2009a) Effects of glutathione on amyloid fibrillation of hen egg-white lysozyme. Int J Biol Macromol 45:321–329

Wang SSS, Liu KN, Lu YC (2009b) Amyloid fibrillation of hen egg-white lysozyme is inhibited by TCEP. Biochem Biophys Res Commun 381:639–642

Wang SSS, Liu KN, Wu CH, Lai JK (2009c) Investigating the influences of redox buffer compositions on the amyloid fibrillogenesis of hen egg-white lysozyme. Biochimica Et Biophysica Acta-Proteins Proteomics 1794:1663–1672

Welker E, Raymond LD, Scheraga HA, Caughey B (2002) Intramolecular versus intermolecular disulfide bonds in prion proteins. J Biol Chem 277:33477–33481

Yagi H, Kusaka E, Hongo K, Mizobata T, Kawata Y (2005) Amyloid fibril formation of α-synuclein is accelerated by preformed amyloid seeds of other proteins. J Biol Chem 280:38609–38616

Yamamoto K, Yagi H, Ozawa D, Sasahara K, Naiki H, Goto Y (2008) Thiol compounds inhibit the formation of amyloid fibrils by [beta]2-microglobulin at neutral pH. J Mol Biol 376:258–268

Zako T, Sakono M, Hashimoto N, Ihara M, Maeda M (2009) Bovine insulin filaments induced by reducing disulfide bonds show a different morphology, secondary structure, and cell toxicity from intact insulin amyloid fibrils. Biophys J 96:3331–3340

Zhang QH, Kelly JW (2003) Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 42:8756–8761

Zhu M, Souillac PO, Ionescu-Zanetti C, Carter SA, Fink AL (2002) Surface-catalyzed amyloid fibril formation. J Biol Chem 277:50914–50922